Form 4: Vanda Pharmaceuticals Director Stephen Ray Mitchell Reports Acquisition and Disposal of Shares
SEC Form 4 Filing
Director Stephen Ray Mitchell reports acquiring and disposing of Vanda Pharmaceuticals shares and stock options on May 17, 2024.
Summary
- On May 17, 2024, Stephen Ray Mitchell, a director of Vanda Pharmaceuticals Inc., reported transactions involving the company's securities.
- Mitchell acquired 20,529 shares of common stock related to a restricted stock unit award (RSU) at $0.
- He also disposed of 20,529 shares of common stock.
- Additionally, Mitchell acquired 37,578 stock options with an exercise price of $5.48.
- These options vest and become exercisable on May 17, 2025, contingent upon continuous service to the Issuer.
- Following these transactions, Mitchell beneficially owns 49,857 shares of common stock and 37,578 stock options.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects standard compensation practices and insider transactions.
Positives
- The acquisition of restricted stock units and stock options indicates confidence in the company's future performance.
Future Outlook
The vesting of the RSU and stock options is contingent upon continuous service to the Issuer through May 17, 2025.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the actions of company directors and officers.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Date of transaction: acquisition and disposal of shares and stock options. |
| 05/17/2025 | Vesting date for the restricted stock units and stock options. |
| 05/16/2034 | Expiration date for the stock options. |
| 05/21/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.